SonALAsense
www.sonalasense.comSonALAsense is a clinical-stage company developing ALA sonodynamic therapy (SDT) as a first-in-class, non-invasive drug-device combination for the treatment of recurrent glioblastoma multiforme (rGBM) and other deadly cancers. SDT utilizes MRI-guided focused ultrasound (the device) in combination with aminolevulinic acid (a drug) to selectively target and kill tumor cells.
Read more
SonALAsense is a clinical-stage company developing ALA sonodynamic therapy (SDT) as a first-in-class, non-invasive drug-device combination for the treatment of recurrent glioblastoma multiforme (rGBM) and other deadly cancers. SDT utilizes MRI-guided focused ultrasound (the device) in combination with aminolevulinic acid (a drug) to selectively target and kill tumor cells.
Read more
Country
State
California
City (Headquarters)
Berkeley
Industry
Employees
1-10
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Medical Officer and Executive Vice President of Development
Email ****** @****.comPhone (***) ****-****President and Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Founder , Chief Medical Officer and Chief Scientific Officer
Email ****** @****.comPhone (***) ****-****Senior Director Clinical Operations
Email ****** @****.comPhone (***) ****-****
Technologies
(21)
